Cerebral Assessment Systems is proud to announce their partnership with two of the largest medical distributors in the world. These deals have been in the process for months, starting after CAS received FDA approval for their computerized cognitive testing device, Cognivue, last June. Both companies are on the Fortune 500 list and are in the top-10 largest medical distributors. Sales representatives from each company, who undergo product-specific training, will be able to market Cognivue to their already established client-base of healthcare providers.
“Though our distribution relationships were only just recently cemented, we have actually already completed our first transaction through our first distributor in NJ,” says Ryan Mooney, sales and distribution manager at CAS. “A true team selling approach was implemented through representation from our corporate office in Rochester NY, our Medsales associate in NJ, and local distributor rep. The first of many more to come.”
This news comes shortly after CAS announced the US commercial launch of Cognivue, and its partnerships with National MedSales Associates, TechTrans, and Maxim Staffing Solutions. By working with well-established companies, CAS can significantly extend its reach, and will be able to provide high-quality products and service to customers in an under-served cognitive healthcare market.